CSI Market
Sign In | Register

Aktis Oncology Inc (AKTS) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AKTS Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Aktis Oncology Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Jun 30 2025) (Mar 31 2025) (Sep 30 2024)
Operating Activities
Income-42.47
Depreciation & amortization1.53
Amortization of Other Assets-1.56
Increase (Decrease) in Deferred Revenue-6.61
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation6.24
Noncash Contribution Expense0.00
Fair Value Adjustment of Warrants0.00
Change In Unrealized Gain Loss On Fair Value Hedging Instruments0.19
Change In Fair Value Of Contingent Real Estate Liability-1.82
Increase Decrease In Other Asset-0.33
Increase Decrease In Change In Other Long Term Liabilities-
Stock Issued-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Liabilities Assumed-
Reclassification Of Fixed Assets To Assets Held For Sale Net-
Gain Loss On Derivative Instruments Net Pretax-
Noncash Interest Payments-
Operating Lease Right Of Use Asset Amortization-
Non Cash Interest Payments-
Operating Lease Right Of Use Asset Amortization Expense-
Increase Decrease In Operating Lease Liability-
Increase Decreasein Other Long Term Liabilities-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Interest and Dividends Receivable1.25
Increase (Decrease) in Accounts Payable0.80
Increase (Decrease) in Other Accrued Liabilities0.00
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets2.45
Other Working Capital1.99
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8.45
Discontinued operations0.00
Net Cash flow from Operating Activities-44.83
Investing Activities
Capital Expenditures-3.12
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities55.40
Short-term Investments Acq.-300.45
Real Estate Investments0.00
Acquisition Business Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-248.17
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock337.70
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Employee Stock Purchase Plan38.93
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities337.70
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-47.95
Total Cash Flow44.71
4 historic quarters locked

Sign in to unlock the full Aktis Oncology Inc cash flow history.

Sign In Create Free Account

About Aktis Oncology Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-349144

Figures are derived from filed reports and may be restated. Historical data is subject to revision.